Search Results - "Gómez‐Velasco, Donají"

Refine Results
  1. 1

    Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk by Sevilla-González, Magdalena Del Rocío, Merino, Jordi, Moreno-Macias, Hortensia, Rojas-Martínez, Rosalba, Gómez-Velasco, Donají Verónica, Manning, Alisa K

    Published in Cardiovascular diabetology (27-02-2021)
    “…Impaired fasting glucose (IFG) is a prevalent and potentially reversible intermediate stage leading to type 2 diabetes that increases risk for cardiometabolic…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Empowerment of patients with type 2 diabetes: current perspectives by Gómez-Velasco, Donají V, Almeda-Valdes, Paloma, Martagón, Alexandro J, Galán-Ramírez, Gabriela A, Aguilar Salinas, Carlos A

    Published in Diabetes, metabolic syndrome and obesity (01-08-2019)
    “…Patient empowerment is a continuous process in which knowledge, motivation, and capacity to take control of their disease are built within a person. This…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Trends in the prevalence of metabolic syndrome and its components in Mexican adults, 2006-2018 by Rojas-Martínez, Rosalba, Aguilar-Salinas, Carlos A, Romero-Martínez, Martín, Castro-Porras, Lilia, Gómez-Velasco, Donaji, Mehta, Roopa

    Published in Salud pública de México (05-11-2021)
    “…To examine trends in the prevalence of metabolic syndrome (MS) and its components. Data from 27 800 Mexican adults who participated in Ensanut 2006, 2012, 2016…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study by Elías-López, Daniel, Vargas-Vázquez, Arsenio, Mehta, Roopa, Cruz Bautista, Ivette, Del Razo Olvera, Fabiola, Gómez-Velasco, Donaji, Almeda Valdes, Paloma, Aguilar-Salinas, Carlos A

    Published in BMC endocrine disorders (28-04-2021)
    “…Whether the metabolically healthy obese (MHO) phenotype is a single, stable or a transitional, fluctuating state is currently unknown. The Mexican-Mestizo…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Development and validation of a screening score for prediabetes and undiagnosed diabetes. by Rojas-Martínez, Rosalba, Escamilla-Núñez, Consuelo, Gómez-Velasco, Donaji V, Zárate-Rojas, Emiliano, Aguilar-Salinas, Carlos A

    Published in Salud pública de México (01-09-2018)
    “…To develop and validate an easy-to-use risk score to detect prediabetes and undiagnosed diabetes in Mexican population. Using information from the Instituto…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Índices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes by Almeda-Valdés, Paloma, Bello-Chavolla, Omar Y, Caballeros-Barragán, César R, Gómez-Velasco, Donají V, Viveros-Ruiz, Tania, Vargas-Vázquez, Arsenio, Aguilar-Salinas, Carlos A

    Published in Gaceta médica de México (2018)
    “…To evaluate the correlation between subrogate index for the evaluation of insulin resistance with the M value obtained with the euglycemic-hyperinsulinemic…”
    Get full text
    Journal Article
  19. 19
  20. 20